These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9764991)

  • 1. Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages.
    Terg R; Llano K; Cobas SM; Brotto C; Barrios A; Levi D; Wasen W; Bartellini MA
    J Hepatol; 1998 Sep; 29(3):437-42. PubMed ID: 9764991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oral ciprofloxacin as selective intestinal decontaminant in cirrhosis.
    Borzio M; Salerno F; Saudelli M; Galvagno D; Piantoni L; Fragiacomo L
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):262-6. PubMed ID: 9646219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats.
    Guarner C; Runyon BA; Heck M; Young S; Sheikh MY
    Dig Dis Sci; 1999 Oct; 44(10):1957-62. PubMed ID: 10548343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The duration of the effect of norfloxacin on the fecal flora in cirrhosis patients].
    Soriano G; Guarner C; Tomás A; Anguera A; Mirelis B; Fernández C; Herrero M; Alonso C; Vilardell F
    Rev Esp Enferm Dig; 1992 May; 81(5):322-6. PubMed ID: 1616740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial.
    Ginés P; Rimola A; Planas R; Vargas V; Marco F; Almela M; Forné M; Miranda ML; Llach J; Salmerón JM
    Hepatology; 1990 Oct; 12(4 Pt 1):716-24. PubMed ID: 2210673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
    Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
    Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes.
    Llovet JM; Rodríguez-Iglesias P; Moitinho E; Planas R; Bataller R; Navasa M; Menacho M; Pardo A; Castells A; Cabré E; Arroyo V; Gassull MA; Rodés J
    J Hepatol; 1997 Jan; 26(1):88-95. PubMed ID: 9148028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
    Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial.
    Rolachon A; Cordier L; Bacq Y; Nousbaum JB; Franza A; Paris JC; Fratte S; Bohn B; Kitmacher P; Stahl JP
    Hepatology; 1995 Oct; 22(4 Pt 1):1171-4. PubMed ID: 7557868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study.
    Terg R; Cobas S; Fassio E; Landeira G; Ríos B; Vasen W; Abecasis R; Ríos H; Guevara M
    J Hepatol; 2000 Oct; 33(4):564-9. PubMed ID: 11059861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily Norfloxacin vs. Weekly Ciprofloxacin to Prevent Spontaneous Bacterial Peritonitis: A Randomized Controlled Trial.
    Yim HJ; Suh SJ; Jung YK; Yim SY; Seo YS; Lee YR; Park SY; Jang JY; Kim YS; Kim HS; Kim BI; Um SH
    Am J Gastroenterol; 2018 Aug; 113(8):1167-1176. PubMed ID: 29946179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ciprofloxacin versus intravenous cefotaxime and ceftriaxone in the treatment of spontaneous bacterial peritonitis.
    Tuncer I; Topcu N; Durmus A; Turkdogan MK
    Hepatogastroenterology; 2003; 50(53):1426-30. PubMed ID: 14571754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral ciprofloxacin on the faecal flora of healthy volunteers.
    Holt HA; Lewis DA; White LO; Bastable SY; Reeves DS
    Eur J Clin Microbiol; 1986 Apr; 5(2):201-5. PubMed ID: 2941281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding.
    Hsieh WJ; Lin HC; Hwang SJ; Hou MC; Lee FY; Chang FY; Lee SD
    Am J Gastroenterol; 1998 Jun; 93(6):962-6. PubMed ID: 9647029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children.
    Qin X; Razia Y; Johnson JR; Stapp JR; Boster DR; Tsosie T; Smith DL; Braden CR; Gay K; Angulo FJ; Tarr PI
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3325-9. PubMed ID: 17005812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacterial infections in liver cirrhosis].
    Papp M; Farkas A; Udvardy M; Tornai I
    Orv Hetil; 2007 Mar; 148(9):387-95. PubMed ID: 17344166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
    Aparicio JR; Such J; Gutiérrez A; Pérez-Mateo M; Plaza J; Arroyo A
    Med Clin (Barc); 1999 Sep; 113(7):241-5. PubMed ID: 10544377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.